SCHEMBL6508436

SCHEMBL6508436

CCOC(=O)c1c(N)c(C(N)=O)nn1-c1ccc(Cl)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.66
KDM4E B2RXH2 5/20 0.66
HPGD P15428 2/20 0.66
HSD17B10 Q99714 1/20 0.66
KMT2A Q03164 2/20 0.54
LMNA P02545 1/20 0.54
MAPT P10636 3/20 0.53
APP P05067 1/20 0.53
CASP1 P29466 1/20 0.53
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
CA9 Q16790 1/20 0.48
P2RY12 Q9H244 1/20 0.47
GABRA2 P47869 1/20 0.46
GABRB2 P47870 1/20 0.46
CHRNA7 P36544 1/20 0.46
PDE4D Q08499 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470606 0.84 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL6469895 0.83 ALDH1A1 (0.51) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL6500282 0.81 ALDH1A1 (0.58) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL6469689 0.80 ALDH1A1 (0.56) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL6467658 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL6504869 0.78 ALDH1A1 (0.54) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL6470216 0.77 ALDH1A1 (0.53) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL6500566 0.74 KDM4E (0.52) ALDH1A1KDM4EHPGDHSD17B10KMT2A
SCHEMBL29719813 0.74 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDHSD17B10MAPT
SCHEMBL6498775 0.74 KDM4E (0.51) ALDH1A1KDM4EHPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ALDH1A1 846/4885KDM4E 2424/4885HPGD 1845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.